However, sequential treatment with CTX and either anti-PDL1 Ab or anti-PDL2 Ab induced a reduction in tumor size that was more pronounced when Abs were co-administered (Figure 4B) leading 60% of mice to survival (Figure 4C). The gene discussed is CD274; the disease is neoplasm.